FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3136283472> ?p ?o ?g. }

• W3136283472 endingPage "825" @default.
• W3136283472 startingPage "817" @default.
• W3136283472 abstract "Abstract Background Metastasectomy is probably underused in metastatic colorectal cancer. The aim of this study was to investigate the effect of centralized repeated assessment on resectability rate of liver metastases. Methods The prospective RAXO study was a nationwide study in Finland. Patients with treatable metastatic colorectal cancer at any site were eligible. This planned substudy included patients with baseline liver metastases between 2012 and 2018. Resectability was reassessed by the multidisciplinary team at Helsinki tertiary referral centre upfront and twice during first-line systemic therapy. Outcomes were resectability rates, management changes, and survival. Results Of 812 patients included, 301 (37.1 per cent) had liver-only metastases. Of these, tumours were categorized as upfront resectable in 161 (53.5 per cent), and became amenable to surgery during systemic treatment in 63 (20.9 per cent). Some 207 patients (68.7 per cent) eventually underwent liver resection or ablation. At baseline, a discrepancy in resectability between central and local judgement was noted for 102 patients (33.9 per cent). Median disease-free survival (DFS) after first resection was 20 months and overall survival (OS) 79 months. Median OS after diagnosis of metastatic colorectal cancer was 80, 32, and 21 months in R0–1 resection, R2/ablation, and non-resected groups, and 5-year OS rates were 68, 37, and 9 per cent, respectively. Liver and extrahepatic metastases were present in 511 patients. Of these, tumours in 72 patients (14.1 per cent) were categorized as upfront resectable, and 53 patients (10.4 per cent) became eligible for surgery. Eventually 110 patients (21.5 per cent) underwent liver resection or ablation. At baseline, a discrepancy between local and central resectability was noted for 116 patients (22.7 per cent). Median DFS from first resection was 7 months and median OS 55 months. Median OS after diagnosis of metastatic colorectal cancer was 79, 42, and 17 months in R0–1 resection, R2/ablation, and non-resected groups, with 5-year OS rates of 65, 39, and 2 per cent, respectively. Conclusion Repeated centralized resectability assessment in patients with colorectal liver metastases improved resection and survival rates." @default.
• W3136283472 created "2021-03-29" @default.
• W3136283472 creator A5000112752 @default.
• W3136283472 creator A5004247399 @default.
• W3136283472 creator A5015216467 @default.
• W3136283472 creator A5024503195 @default.
• W3136283472 creator A5027413847 @default.
• W3136283472 creator A5033132182 @default.
• W3136283472 creator A5033807509 @default.
• W3136283472 creator A5037442839 @default.
• W3136283472 creator A5042344249 @default.
• W3136283472 creator A5050524879 @default.
• W3136283472 creator A5050914625 @default.
• W3136283472 creator A5062725034 @default.
• W3136283472 creator A5063402192 @default.
• W3136283472 creator A5067706002 @default.
• W3136283472 creator A5068373412 @default.
• W3136283472 creator A5069231583 @default.
• W3136283472 creator A5069477717 @default.
• W3136283472 creator A5071129657 @default.
• W3136283472 creator A5072745978 @default.
• W3136283472 date "2021-03-22" @default.
• W3136283472 modified "2023-10-18" @default.
• W3136283472 title "Centralized repeated resectability assessment of patients with colorectal liver metastases during first-line treatment: prospective study" @default.
• W3136283472 cites W1975108860 @default.
• W3136283472 cites W1994745565 @default.
• W3136283472 cites W2007900522 @default.
• W3136283472 cites W2052146702 @default.
• W3136283472 cites W2056055025 @default.
• W3136283472 cites W2057156320 @default.
• W3136283472 cites W2085633477 @default.
• W3136283472 cites W2092143175 @default.
• W3136283472 cites W2095137583 @default.
• W3136283472 cites W2100471896 @default.
• W3136283472 cites W2114857812 @default.
• W3136283472 cites W2125877119 @default.
• W3136283472 cites W2140085392 @default.
• W3136283472 cites W2144326782 @default.
• W3136283472 cites W2145564580 @default.
• W3136283472 cites W2284450191 @default.
• W3136283472 cites W2325443151 @default.
• W3136283472 cites W2397463777 @default.
• W3136283472 cites W2470575266 @default.
• W3136283472 cites W2564651545 @default.
• W3136283472 cites W2599514290 @default.
• W3136283472 cites W2605987398 @default.
• W3136283472 cites W2607004621 @default.
• W3136283472 cites W2738694813 @default.
• W3136283472 cites W2769283728 @default.
• W3136283472 cites W2887684706 @default.
• W3136283472 cites W2964396816 @default.
• W3136283472 cites W2973157702 @default.
• W3136283472 cites W2977571468 @default.
• W3136283472 cites W3035470988 @default.
• W3136283472 doi "https://doi.org/10.1093/bjs/znaa145" @default.
• W3136283472 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33749772" @default.
• W3136283472 hasPublicationYear "2021" @default.
• W3136283472 type Work @default.
• W3136283472 sameAs 3136283472 @default.
• W3136283472 citedByCount "22" @default.
• W3136283472 countsByYear W31362834722021 @default.
• W3136283472 countsByYear W31362834722022 @default.
• W3136283472 countsByYear W31362834722023 @default.
• W3136283472 crossrefType "journal-article" @default.
• W3136283472 hasAuthorship W3136283472A5000112752 @default.
• W3136283472 hasAuthorship W3136283472A5004247399 @default.
• W3136283472 hasAuthorship W3136283472A5015216467 @default.
• W3136283472 hasAuthorship W3136283472A5024503195 @default.
• W3136283472 hasAuthorship W3136283472A5027413847 @default.
• W3136283472 hasAuthorship W3136283472A5033132182 @default.
• W3136283472 hasAuthorship W3136283472A5033807509 @default.
• W3136283472 hasAuthorship W3136283472A5037442839 @default.
• W3136283472 hasAuthorship W3136283472A5042344249 @default.
• W3136283472 hasAuthorship W3136283472A5050524879 @default.
• W3136283472 hasAuthorship W3136283472A5050914625 @default.
• W3136283472 hasAuthorship W3136283472A5062725034 @default.
• W3136283472 hasAuthorship W3136283472A5063402192 @default.
• W3136283472 hasAuthorship W3136283472A5067706002 @default.
• W3136283472 hasAuthorship W3136283472A5068373412 @default.
• W3136283472 hasAuthorship W3136283472A5069231583 @default.
• W3136283472 hasAuthorship W3136283472A5069477717 @default.
• W3136283472 hasAuthorship W3136283472A5071129657 @default.
• W3136283472 hasAuthorship W3136283472A5072745978 @default.
• W3136283472 hasBestOaLocation W31362834721 @default.
• W3136283472 hasConcept C121608353 @default.
• W3136283472 hasConcept C126322002 @default.
• W3136283472 hasConcept C141071460 @default.
• W3136283472 hasConcept C188816634 @default.
• W3136283472 hasConcept C2778601017 @default.
• W3136283472 hasConcept C2779013556 @default.
• W3136283472 hasConcept C3019894029 @default.
• W3136283472 hasConcept C526805850 @default.
• W3136283472 hasConcept C71924100 @default.
• W3136283472 hasConceptScore W3136283472C121608353 @default.
• W3136283472 hasConceptScore W3136283472C126322002 @default.
• W3136283472 hasConceptScore W3136283472C141071460 @default.
• W3136283472 hasConceptScore W3136283472C188816634 @default.
• W3136283472 hasConceptScore W3136283472C2778601017 @default.

• next